This press release does not constitute an offer to sell or the solicitation of offers to buy any securities of Inovio, and shall not constitute an offer, solicitation or sale of any security in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

NASHVILLE, Tenn., May 31, 2012 /PRNewswire/ -- Parents in Tennessee may be unaware that their adolescent children are at risk of contracting a serious, potentially fatal bacterial infection

Researchers at Baylor College of Medicine will receive up to $6.2 million over five years from the National Institute Of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a vaccine for severe acute respiratory syndrome, commonly called SARS.

SALT LAKE CITY, May 30, 2012 /PRNewswire/ -- Parents in Utah may be unaware that their adolescent children are at risk of contracting a potentially fatal bacterial infection called meningococcal

LOUISVILLE, Ky., May 30, 2012 /PRNewswire/ -- Parents in Kentucky may be unaware that their adolescent children are at risk of contracting a serious, potentially fatal bacterial infection